Evidence map›Paper›PMID 32866424›Full record

ArticleAutophagy2021

Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial.

Inge Compter, Danielle B P Eekers, Ann Hoeben, Kasper M A Rouschop, Bart Reymen, Linda Ackermans, Jan Beckervordersantforth, Noel J C Bauer, Monique M Anten, Pieter Wesseling and 3 more

Abstract readClinical Trial, Phase I
In one paragraph

Article in Autophagy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Chromosomal Instability Drives Glioblastoma Heterogeneity and Therapeutic Opportunities.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  7. Article
  8. Article
  9. The CHI3L1 protein plays role as a protecting factor against autophagy in glioblastoma cells.Apoptosis : an international journal on programmed cell death · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Targeting Lysosomes for Enhanced Anti-Cancer Therapeutics and Immune Response.International journal of biological sciences · 2026
    Review
  17. Review
  18. Article
  19. Review
  20. Review

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Inge CompterDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Danielle B P EekersDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Ann HoebenDepartment of Medical Oncology, GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Kasper M A RouschopDepartment of Radiotherapy, GROW School for Oncology, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-4208-5415
Bart ReymenDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Linda AckermansDepartment of Neurosurgery, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Jan BeckervordersantforthDepartment of Pathology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Noel J C BauerDepartment of Ophthalmology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Monique M AntenDepartment of Neurology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Pieter WesselingDepartment of Pathology, Amsterdam University Medical Centers/VUmc, Amsterdam, The Netherlands.ORCID 0000-0001-5453-5201
Alida A PostmaDepartment of Radiology and Nuclear Medicine, School for Mental Health and Sciences, Maastricht University Medical Centre+, Maastricht University Medical Center, Maastricht, The Netherlands.
Dirk De RuysscherDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Philippe LambinDepartment of Radiology and Nuclear Medicine, School for Mental Health and Sciences, Maastricht University Medical Centre+, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0001-7961-0191

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of glioblastoma xenografts with chloroquine results in macroautophagy/autophagy inhibition, resulting in a reduction of tumor hypoxia and sensitization to radiation. Preclinical data show that

Indexed as

Brain NeoplasmsChemoradiotherapyChloroquineGlioblastomaAutophagyHumansTemozolomideTreatment OutcomeChloroquineTemozolomideAutophagybrain tumorchloroquineglioblastomaradiotherapytemozolomide

Identifiers

PMID32866424
PMCPMC8496728

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.